You are here: Home ยป Archives for Miscellaneous

Countdown For A Cure Raises Over $1 Million at 2026 Evening of Energy Gala

2026 Evening of Energy Gala

A Media Snippet accompanying this announcement is available by clicking on this link.

ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) — Countdown For A Cure (CFAC) hosted its third annual Evening of Energy gala on February 7th at The St. Regis Atlanta, raising more than $1 million to advance mitochondrial research focused on cellular energy, the foundation of human health.

Hosted by Dr. Taz Bhatia, MD, nationally recognized integrative physician and founder of hol+, the evening brought together leaders across science, medicine, wellness, philanthropy, and culture to highlight the growing relevance of mitochondrial science in chronic illness, aging, and rare disease.

During the program, CFAC presented its highest honor, the Countdown For A Cure Award, to Douglas C. Wallace, PhD, Director of the Center for Mitochondrial & Epigenomic Medicine at Children’s Hospital of Philadelphia. Widely regarded as the father of mitochondrial medicine, Dr. Wallace was recognized for pioneering discoveries that established the role of mitochondria in human health, disease, and aging.

The 2026 Powerhouse Award was presented to Sonya Knebel, 2022 European Long Drive Champion and 2022 World Long Drive Bronze Medalist, honoring her leadership and advocacy following her experience with mitochondrial dysfunction.

The evening also featured remarks from Natalie Yivgi-Ohana, PhD, Founder and CEO of Minovia Therapeutics and 2025 CFAC grant recipient. Through its 2025 grant, CFAC is specifically supporting mitochondrial biomarker development, advancing tools to measure cellular function, track disease progression, and assess therapeutic response with greater precision. This work is critical to accelerating clinical translation and evaluating next-generation mitochondrial therapies.

The program blended science and storytelling, with a live performance by Izabela Rose and an after-party led by Grammy Award-winning producer DJ Babey Drew.

The 2026 Evening of Energy was made possible through the support of sponsors, including InPrime Legal and MoveDocs. “In science, Mitzi and Jeff are solving for the root cause,” said Jonathan Page, Founder of InPrime Legal. “They are building the foundation for the future of health.”

Funds raised will support CFAC’s expanding research pipeline and education initiatives, with additional 2026 grant announcements planned this spring.

“Disease moves quickly. To truly change lives, we have to move faster,” said Co-Founders Mitzi and Jeff Solomon. “Our third annual Evening of Energy reflects a powerful truth: when a community unites around bold science, progress accelerates. We are thankful for every partner and supporter helping advance mitochondrial research. But this is only the beginning. Together, we must continue to move with the speed and scale this work requires and deserves.”

The next Evening of Energy gala will take place on January 30, 2027, at The St. Regis Atlanta. Sponsorship opportunities are now available, and sponsors who commit before April 1st will receive enhanced recognition and access to an exclusive Founders experience.

For more information about Countdown For A Cure, sponsorship opportunities, or ways to get involved, visit www.CountdownForACure.org or email [email protected].

About Countdown For A Cure
Countdown For A Cure is the only nonprofit dedicated to accelerating broad mitochondrial science and medicine. The organization funds innovative research, elevates awareness of mitochondrial dysfunction as a critically overlooked driver of disease, and works to bring mitochondrial health out of the shadows and into everyday conversations about vitality, resilience, and longevity. Guided by the belief that Energy Is Everything, Countdown For A Cure is building a movement to transform preventive care and improve healthspan for today and for generations to come.

About the Evening of Energy Gala
The Evening of Energy is Countdown For A Cure’s signature annual fundraising gala, convening leaders across science, medicine, biotechnology, philanthropy, and wellness to advance mitochondrial research. The event highlights groundbreaking science, personal stories, and cross-sector partnerships centered on the role of cellular energy in human health. Proceeds support research, education, and collaboration to accelerate discoveries with broad impact.

The next Evening of Energy will take place on January 30, 2027. Sponsorship opportunities are available; commitments prior to April 1st will receive enhanced recognition and access to an exclusive Founders experience. For more information, visit www.CountdownForACure.org or email [email protected].

For more information, visit www.CountdownForACure.org

Follow CFAC on Instagram, Facebook, LinkedIn, X and YouTube

Contact:
Mitzi Solomon, Founder and President
[email protected] | +1 (917) 715-2381


GLOBENEWSWIRE (Distribution ID 9660360)

Petroleum Development Oman Awards Lufkin Industries Multi-Year Contract for Rod Driven Progressive Cavity Pump Systems (RDPCP) for South Oman

MUSCAT, Oman, Feb. 24, 2026 (GLOBE NEWSWIRE) — Lufkin Industries (“Lufkin”), a global leader in artificial lift solutions, has been awarded by Petroleum Development Oman’s (“PDO”), a multi-year performance contract to deliver Rod Driven Progressive Cavity Pumping (“RDPCP”) systems across the Marmul-Rahab-Thuleilat-Qaharir (Marmul and RTQ) fields. The award solidifies Lufkin’s position as one of PDO’s most trusted long-term partners in production optimization and field execution.

The win extends Lufkin’s successful partnership with PDO, which began in the early 2000’s and has consistently delivered asset reliability, engineering innovation, and strong localization outcomes in Oman’s oilfields. Under the new Marmul-RTQ award, Lufkin will continue supplying high-performance RDPCP equipment, deployment services, and production optimization support.

“This award reaffirms the strength of our partnership with PDO and our shared commitment to long-term field success,” said Brent Baumann, Chief Executive Officer of Lufkin. “From day one, we’ve focused on delivering not just reliable artificial lift systems, but a broader ecosystem of service, innovation, and localization wrapped in safety that supports Oman’s production goals. We’re honored to continue building on this foundation with Marmul-RTQ.”

Over the past twenty years, Lufkin has become a top performer in Oman’s artificial lift market, achieving:

  • Over 2,000 Rod Lift Systems installed
  • Zero Non-Productive Time across new well deployments and replacements
  • An average pump run life of over 763 days for PCP Systems
  • ‘Quarterly Performance Review’ scores consistently “On Target” and “Above Target”
  • Published technical papers in collaboration with PDO and a leading industrial partner, including breakthroughs in remote-controlled RDPCP operations as well as co-presentations with PDO at the SPE workshop in Cartegena, Colombia – all affirming Lufkin’s commitment to develop PCP optimization programs for PDO and the industry

“Our teams have earned trust in the field through consistency, technical excellence and collaboration,” said Craig Guillory, Vice President International Sales & Operations at Lufkin. “This win is not only a validation of our past performance but a challenge we’re proud to take on. We’re committed to delivering the same high standards in Marmul and RTQ that PDO has come to expect from Lufkin.”

Invested in Oman – Local Talent, Local Infrastructure

Lufkin’s approach to the Marmul-RTQ execution will continue emphasizing In Country Value. Currently, 87% of Lufkin’s field teams in Oman are local nationals, and the company has built up robust in-country infrastructure to support deployment, service, and optimization.

“Lufkin has proven itself as a high-performance partner for PDO. Their ability to deliver at an elevated level in any condition while also heavily investing in local capability development has made them a strategic part of our long-term production ecosystem.” – Statement from PDO.

The awarded scope will cover new well installations, workovers, optimization services, and life-of-well RDPCP support for Marmul and RTQ; a mission-critical portfolio for PDO’s future production targets.

Learn more about Lufkin PCP Systems: Progressing Cavity Pumps – LUFKIN Industries

About LUFKIN Industries
Lufkin Industries is a leading global provider of rod lift optimization solutions, products, technologies, and services to the oil and gas industry. With over 100 years of industry leadership, LUFKIN manufactures a complete line of surface pumping units, sucker rods, downhole sucker rod pumps and automation systems worldwide. The company is recognized around the world as the industry standard and the benchmark others strive to attain. LUFKIN’s intelligent solutions are supported by an extensive global service footprint, staffed with highly skilled technicians capable of solving the most challenging well concerns.

Discover more at www.lufkin.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bdda487d-85b0-41e0-82d6-3853aa485d1e


GLOBENEWSWIRE (Distribution ID 9659732)

WALLIX reinforces its strategic footprint in the Middle East as demand for digital sovereignty accelerates

Paris, France – February 24, 2026, WALLIX (Euronext ALLIX), a European cybersecurity software vendor specializing in Identity and Access Management (IAM) and a recognized European leader in Privileged Access Management (PAM), marks 10 years of sustained growth in the Middle East. The region is a major contributor to the Group’s performance momentum. In 2025, WALLIX reported +37% growth in recurring revenue across EMEA (excluding France), driven in particular by approximately +40% growth in the Middle East–Africa region. Against a backdrop of escalating cyber threats and increasing digital sovereignty requirements, WALLIX continues to strengthen its position as a strategic partner in protecting critical infrastructure across the region.

A decade of local presence supporting digital sovereignty
Established in the Middle East for over ten years, WALLIX has built a strong regional footprint supported by an experienced local team and a network of more than 40 certified partners covering all Gulf countries. The company also offers local hosting facilities, addressing the growing demand for in-country data residency within national jurisdictions. This footprint is built on a “Channel First” strategy, driven by high-value-added distributors such as Cloud Dubai and SCOPE Middle East, ensuring organizations across the region rapid access to WALLIX solutions, close customer support, and agile deployment capabilities at scale.
This local presence has translated into robust performance. The Middle East–Africa region is now WALLIX’s second-largest geographic area and the leading contributor within EMEA, with growth close to 40%. Several significant contracts have recently been secured in the Middle East, including projects to secure industrial OT environments across the utilities, healthcare, and construction sectors. These wins underscore WALLIX’s commercial momentum and its ability to address the security challenges of critical infrastructure throughout the region.

« The Middle East is not a region to conquer for WALLIX, it has been part of our story since the company’s early days, often in geographically extreme and fascinating environments. Our very first commercial customer came from the Gulf region, and for more than ten years, we have built enduring relationships here with teams, partners, and customers who trust us every day,» said Ahmed Bouzid, VP Sales Middle East Africa at WALLIX.  « Today, our priority is to support the United Arab Emirates and the Kingdom of Saudi Arabia in securing both their IT and industrial OT environments with solutions that are simple, adaptable to local requirements, sovereign, and immediately operational. Solutions where architecture and customer data remain independent from sometimes intrusive extraterritorial regulations that may not be aligned with local contexts.»
Digital sovereignty: a credible European alternative
Digital sovereignty has become both an economic and strategic imperative. In the United Arab Emirates and the Kingdom of Saudi Arabia, organizations are seeking solutions capable of protecting critical assets while complying with local data governance and regulatory requirements. In a global environment where certain digital and cybersecurity technologies may be subject to extraterritorial legislation and foreign legal constraints, WALLIX promotes an independent European approach. The company delivers security solutions designed to protect national sovereignty, preserve state autonomy, and ensure full sovereign control over critical systems and sensitive data. WALLIX relies on internationally recognized standards such as ISO 27001 and offers solutions certified under the highest European security frameworks, including trusted schemes from ANSSI (France) and BSI (Germany). The company supports national initiatives aligned with the United Arab Emirates’s National Cybersecurity Strategy, the  Kingdom of Saudi Arabia’s Vision 2030, and compliance frameworks across highly regulated sectors such as finance, energy, healthcare, utilities, and government.

WALLIX One: a unified, high-performance, and agile cyber platform
As digital transformation accelerates, WALLIX supports Middle Eastern organizations in securing complex and often sensitive IT and industrial OT environments through its unified platform, WALLIX One.
The platform provides comprehensive identity and access protection, including human and non-human access control, privilege management, session monitoring and traceability, and access governance (internal, third-party, and machine-based identities). Designed for ease of adoption and rapid deployment, WALLIX One enables organizations to scale at their own pace, depending on cyber maturity, asset criticality, and operational or budgetary constraints. Deployment options include on-premises, cloud, hybrid, or managed services, allowing organizations to select the model best suited to their industry and business model, without unnecessary complexity or over-engineering.

About WALLIX
Listed on Euronext (ALLIX) since 2015, WALLIX is a European cybersecurity software vendor and a recognized European leader in Privileged Access Management (PAM). WALLIX supports public and privatorganizations in securing identities and access, strengthening operational resilience, regulatory compliance, and digital autonomy. Today, the unified WALLIX One platform protects more than 4,000 organizations worldwide. It secures identities, user access, and privileged accounts across both digital (IT) and industrial (OT) environments, enabling organizations to operate securely and evolve confidently in an increasingly complex and interconnected digital world.
www.wallix.com | [email protected]

FINANCIAL COMMUNICATION CONTACTS
ACTUS Finance & Communication
Investor Relations – Hélène de Watteville
+33 (0)1 53 67 36 33 / [email protected]

Press Relations – Déborah Schwartz+33 (0)6 27 09 05 73 / [email protected]


GLOBENEWSWIRE (Distribution ID 1001166227)

LYB announces updated 2030 sustainability goals

HOUSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) — LyondellBasell (NYSE:LYB) today announced updates to its 2030 climate and circularity goals amid the need for disciplined capital allocation, evolving market conditions and regulatory developments. The goals remain ambitious, while balancing the need to adjust for near-term achievability. The company’s three-pillared strategy remains unchanged: growing and upgrading the core, building a profitable circular and low-carbon business, and stepping up performance and culture. To ensure alignment with the strategy and reflect the realities of today’s operating environment, the updated goals are as follows:

  • Scope 1 and 2 greenhouse gas emissions reduction: 32% by 2030, relative to a 2020 baseline.1
  • Circularity: produce and market 800,000 metric tons of recycled and renewable-based polymers annually by 2030.2

“Over the past several years, we have made measurable progress and gained a deeper understanding of factors that enable us to deliver value from circular and low carbon solutions, including the pace of policy adoption and implementation, market demand and technology readiness. At the same time, maintaining capital discipline is essential in the current economic environment,” said Peter Vanacker, chief executive officer of LYB. “We will continue to create value for our stakeholders through being a leader in sustainability in the chemical industry and executing our strategy. These updates to our goals ensure we remain focused on advancing sustainability as a key value driver of our business at a pace aligned with market conditions and the regulatory environment.”

To date, the company has achieved significant milestones, including advancing construction of the MoReTec-1 plant, the company’s first commercial-scale catalytic chemical recycling plant using its proprietary MoReTec technology in Wesseling, Germany, targeting future profitable growth in circular and low-carbon solutions. The company has also made progress in reducing emissions, including at the Houston Refinery site, and through value-creating energy efficiency measures at its manufacturing sites via its Value Enhancement Program, and securing sufficient projects to reach the company target of procuring a minimum of 50% of electricity from renewable sources by 2030 (based on 2020 procured levels).

The updated goals will not impact supply commitments or commercial contracts.

Details on LyondellBasell's refreshed sustainability approach and the enablers that impact the achievement of its sustainability goals will be shared in the company’s annual Sustainability Report in April 2026.

About LyondellBasell

We are LyondellBasell (NYSE: LYB) – a leader in the global chemical industry creating solutions for everyday sustainable living. Through advanced technology and focused investments, we are enabling a circular and low carbon economy. Across all we do, we aim to unlock value for our customers, investors and society. As one of the world's largest producers of polymers and a leader in polyolefin technologies, we develop, manufacture and market high-quality and innovative products for applications ranging from sustainable transportation and food safety to clean water and quality healthcare. For more information, please visit www.lyondellbasell.com or follow @LyondellBasell on LinkedIn.

Forward-Looking Statements
The statements in this release relating to matters that are not historical facts are forward-looking statements. These forward-looking statements are based upon the expectations and assumptions of management of LyondellBasell, including expectations based on third-party information and projections, which are believed to be reasonable at the time made and are subject to significant risks and uncertainties. When used in this release, the words “intend,” “may,” “plan,” “potential,” “strategy,” “goal,” “ambition,” “”achieve,” “pathway,” “enable,” “target,” “should,” “will,” “expect,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. In addition, any statements that refer to LyondellBasell's sustainability goals and related efforts are forward-looking statements. Actual results could differ materially based on factors including, but not limited to, market conditions, the business cyclicality of the chemical, polymers and refining industries; the availability, cost and price volatility of raw materials and utilities, particularly the cost of oil, natural gas, and associated natural gas liquids; our ability to meet our sustainability goals, including the ability to  operate safely,  increase production of recycled and renewable-based polymers, and reduce our greenhouse gas emissions and energy usage; implementation of new technology and the ability to realize the expected benefits therefrom; our ability to access capital to fund our climate related initiatives; our ability to complete construction and successfully operate MoReTec-1; actions by our suppliers and customers, including the use of the Circulen family of products; our ability to procure renewable energy and reduce our reliance on coal; competitive product and pricing pressures; labor conditions; operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, supplier disruptions, labor shortages, strikes, work stoppages or other labor difficulties, transportation interruptions, spills and releases and other environmental risks); the supply/demand balances for our and our joint ventures' products, and the related effects of industry production capacities and operating rates; our ability to manage costs; future financial and operating results; climate change developments; legal and environmental proceedings; tax rulings, consequences or proceedings; technological developments, and our ability to develop new products and process technologies; and potential governmental regulatory actions, including climate related disclosure requirements. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the “Risk Factors” section of our Form 10-K for the year ended December 31, 2026 and in our subsequent filings with the SEC, which can be found at www.LyondellBasell.com on the Investors page and on the Securities and Exchange Commission's website at www.sec.gov.

Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements, and are urged to carefully review and consider the disclosures, including but not limited to those regarding the risks we face, in the documents we file from time to time with the Securities and Exchange Commission. There is no assurance that any of the actions, events or results of the forward-looking statements will occur, or if any of them do, what impact they will have on our ability to achieve our strategies or goals, our results of operations or our financial condition. Many of the standards, metrics, technology and assumptions used in preparing the company's goals and strategy continue to evolve and are based on management assumptions believed to be reasonable at the time of preparation but should not be considered guarantees. Forward-looking statements speak only as of the date they were made and are based on the estimates and opinions of management of LyondellBasell at the time the statements are made. LyondellBasell does not assume, and expressly disclaims, any obligation to update forward-looking statements should circumstances or management's estimates or opinions change, except as required by law. The company is not obligating itself to provide any specific disclosure in the future (including with respect to the goals and progress reported herein), except as it determines to do so.

Source: LyondellBasell Industries

Media Contact: Nick Facchin +1 713-309-4791

1 Previous goal: 42% reduction by 2030, relative to a 2020 baseline.
2 Previous goal: produce and market 2 million metric tons of recycled and renewable-based polymers annually by 2030. Production and marketing includes: joint venture production marketed by LYB plus our pro rata share of the remaining production produced and marketed by the joint venture, and production via third-party tolling arrangements.


GLOBENEWSWIRE (Distribution ID 9659131)

Pakistan Establishes Its Sovereign AI Position with the Adoption of the Islamabad AI Declaration

Islamabad, Pakistan, Feb. 20, 2026 (GLOBE NEWSWIRE) — Following the high-level proceedings of the Indus AI Summit 2026, the Government of Pakistan has formally adopted the Islamabad AI Declaration on Sovereign, Responsible, and Capability-Driven Artificial Intelligence. The Declaration defines Pakistan’s national position on Artificial Intelligence and marks the transition from policy articulation to disciplined national execution.

Formally presented by the Federal Minister for Information Technology and Telecommunication, Ms. Shaza Fatima Khawaja, the Declaration affirms Pakistan’s sovereign and inclusive approach to Artificial Intelligence, led by the private sector and enabled by government, to advance Digital Society, Digital Economy, and Digital Governance.

The Declaration sets out nine foundational principles that will guide Pakistan’s national AI ecosystem:

  1. AI as a sovereign choice aligned with constitutional objectives and measurable public value
  2. Human accountability and institutional oversight in all decisions of public consequence
  3. A pragmatic, use-case-first deployment model anchored in economic productivity and service delivery
  4. Sovereign data stewardship under Pakistan’s legal and constitutional framework
  5. Explainable, auditable, and risk-proportionate AI systems
  6. Coordinated, whole-of-government governance to prevent fragmentation and vendor dependency
  7. Investment in national capability, research, and inclusive innovation
  8. A private-sector-led AI economy supported by sovereign compute and resilient infrastructure
  9. Principled international engagement consistent with national values and sovereign interests

Federal Minister for Information Technology and Telecommunication, Ms. Shaza Fatima Khawaja, stated:

“The Islamabad AI Declaration is a foundational step in strengthening Pakistan’s digital economy. Under the Prime Minister’s vision to harness AI for public good and economic growth, this framework provides a disciplined roadmap to create jobs, enable enterprise, and build long-term competitiveness. Our youth are our greatest strategic asset, and AI will be a catalyst for inclusive prosperity.”

Dr. Sohail Munir, Chairperson of the Pakistan Digital Authority, the national authority responsible for AI governance, regulatory oversight, and supervisory coordination in Pakistan, added:

“The Declaration establishes the foundations for AI governance and supervision in Pakistan and reflects a disciplined commitment to sovereignty, public trust, and measurable national value. Pakistan will adopt AI responsibly, govern it rigorously, and build domestic capability with accountability.

The Ministry of Information Technology and Telecommunication, in coordination with the Pakistan Digital Authority and relevant federal and provincial institutions, has initiated the integration of the Declaration’s principles into supervisory frameworks, procurement standards, sectoral adoption roadmaps, and institutional capability programs.

The Honourable Prime Minister has directed the Pakistan Digital Authority to operationalize and enforce a national AI Supervisory Framework aligned with the Declaration and to develop the necessary legal and governance architecture to ensure structured, accountable AI adoption across the country.

With this adoption, Pakistan formally enters a new phase of sovereign, responsible, and capability-driven AI development.

Attachment


GLOBENEWSWIRE (Distribution ID 9658313)

Nyxoah Annonce la Signature d'un Mémorandum d'Accord avec l'Hôpital Sheikh Shakhbout Medical City afin d'Améliorer la Prise en Charge du Traitement de l'AOS et d'Accélérer l'Accès à Genio au Moyen-Orient

Nyxoah Annonce la Signature d'un Mémorandum d'Accord avec l'Hôpital Sheikh Shakhbout Medical City afin d'Améliorer la Prise en Charge du Traitement de l'AOS et d'Accélérer l'Accès à Genio au Moyen-Orient

Mont-Saint-Guibert, Belgique – 18 février 2026, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « Société ») une société de technologie médicale spécialisée dans le développement et la commercialisation de solutions innovantes pour le traitement de l'Apnée Obstructive du Sommeil (« AOS ») par neuromodulation, a annoncé aujourd'hui la poursuite de ses efforts visant à renforcer sa présence au Moyen-Orient grâce à la signature d'un protocole d'accord avec Sheikh Shakhbout Medical City (SSMC), un hôpital phare des Émirats arabes unis spécialisé dans les soins complexes et graves, filiale de PureHealth, le plus grand groupe de soins de santé du Moyen-Orient. Ce protocole d'accord reflète l'orientation stratégique de Nyxoah, qui consiste à collaborer avec les centres médicaux régionaux d’excellence afin d'élargir l'accès à sa thérapie de stimulation du nerf hypoglosse (HGNS) Genio®, tout en soutenant les normes les plus élevées en matière de soins cliniques, d'éducation et de collaboration scientifique.

Dans le cadre de ce protocole d'accord, Nyxoah et SSMC s'engagent dans des initiatives visant à positionner SSMC comme un centre régional de premier plan pour la thérapie Genio. Ces efforts ont pour but de soutenir le développement d'un programme d'implantation à grand volume axé sur les soins centrés sur le patient.

Parallèlement, cette collaboration prévoit de faire du SSMC un centre régional de formation à la thérapie Genio au Moyen-Orient afin de soutenir la formation des chirurgiens, des médecins spécialistes du sommeil et des professionnels de santé référents de toute la région.

Nyxoah et le SSMC sont également engagés dans des discussions visant à explorer la recherche clinique et la collaboration dans le domaine de l'apnée du sommeil et de la prise en charge des maladies chroniques et métaboliques.

Olivier Taelman, Chief Executive Officer de Nyxoah, a commenté : “Compte tenu de la forte prévalence de l'apnée obstructive du sommeil au Moyen-Orient, cette initiative soutient notre vision d'offrir de nouvelles options de traitement aux patients de la région et d'explorer davantage l'impact de la prise en charge avancée de l'AOS sur les maladies chroniques et métaboliques telles que le diabète de type 2. Notre engagement actif auprès de Sheikh Shakhbout Medical City reflète notre stratégie de partenariat avec des institutions de premier plan afin de mettre en place des programmes cliniques durables, de soutenir la formation des médecins et de contribuer à l'amélioration des soins prodigués aux patients atteints d'apnée obstructive du sommeil.”

Dr. Marwan Al Kaabi, Chief Executive Officer de Sheikh Shakhbout Medical City, a ajouté : “À Sheikh Shakhbout Medical City, nous nous engageons à promouvoir des soins spécialisés et de haute qualité grâce à l'excellence clinique, à l'éducation et à la recherche. Notre collaboration avec Nyxoah soutient nos efforts visant à développer davantage notre expertise dans les thérapies innovantes contre l'apnée du sommeil et à servir de centre régional de référence pour la formation et les échanges scientifiques.”

À propos de Nyxoah
Nyxoah opère dans le secteur des technologies médicales. Elle se concentre sur le développement et la commercialisation de solutions innovantes destinées à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS). La principale solution de Nyxoah est le système Genio®, une thérapie de neurostimulation du nerf hypoglosse sans sonde et sans batterie qui a reçu le marquage CE, centrée sur le patient et destinée à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS), le trouble respiratoire du sommeil le plus courant au monde. Ce dernier est associé à un risque accru de mortalité et des comorbidités, dont les maladies cardiovasculaires. La visions de Nyxoah est que les patients souffrant de SAOS doivent pouvoir profiter de nuits réparatrices et vivre pleinement leur vie.

À la suite de la finalisation probante de l’étude BLAST OSA, le système Genio® a reçu le marquage européen CE en 2019. Nyxoah a réalisé avec succès deux IPO : l’une sur Euronext Bruxelles en septembre 2020 et l’autre sur le NASDAQ en juillet 2021. Grâce aux résultats positifs de l'étude BETTER SLEEP, Nyxoah a reçu le marquage CE pour l’extension de ses indications thérapeutiques aux patients souffrant de collapsus concentrique complet (CCC), pour lesquels les thérapies concurrentes sont actuellement contre-indiquées. En outre, la Société a annoncé les résultats positifs de l'étude pivot DREAM IDE et l'obtention de l'autorisation de la FDA pour un sous-groupe de patients adultes atteints d'AOS modérée à sévère avec un IAH supérieur ou égal à 15 et inférieur ou égal à 65.

Pour plus d’informations, visitez www.nyxoah.com

Attention – Marquage CE depuis 2019. Approuvé par la FDA en août 2025 en tant que dispositif disponible uniquement sur prescription médicale.

DÉCLARATIONS PROSPECTIVES
Certaines déclarations, convictions et opinions contenues dans ce communiqué de presse sont de nature prospective et reflètent les attentes actuelles de la Société ou, le cas échéant, de ses administrateurs ou de sa direction concernant le système Genio ; les études cliniques prévues et en cours sur le système Genio ; les avantages potentiels du système Genio ; les objectifs de Nyxoah en matière de développement, de parcours réglementaire et d'utilisation potentielle du système Genio ; la stratégie de commercialisation de la société et son entrée sur le marché américain ; et les résultats d'exploitation, la situation financière, la liquidité, les performances, les perspectives, la croissance et les stratégies de la société. De par leur nature, les déclarations prospectives comportent un certain nombre de risques, d'incertitudes, d'hypothèses et d'autres facteurs qui pourraient faire en sorte que les résultats ou événements réels diffèrent sensiblement de ceux exprimés ou sous-entendus dans les déclarations prospectives. Ces risques, incertitudes, hypothèses et facteurs pourraient avoir une incidence défavorable sur les résultats et les effets financiers des plans et événements décrits dans le présent document. En outre, ces risques et incertitudes comprennent, sans s'y limiter, les risques et incertitudes énoncés dans la section « Facteurs de risque » du rapport annuel de la société sur le formulaire 20-F pour l'exercice clos le 31 décembre 2024, déposé auprès de la Securities and Exchange Commission (« SEC ») le 20 mars 2025, et dans les rapports ultérieurs que la Société dépose auprès de la SEC. Une multitude de facteurs, y compris, mais sans s'y limiter, les changements dans la demande, la concurrence et la technologie, peuvent faire en sorte que les événements, les performances ou les résultats réels diffèrent considérablement de toute évolution prévue. Les déclarations prospectives contenues dans le présent communiqué de presse concernant les tendances ou activités passées ne constituent pas des garanties de performances futures et ne doivent pas être interprétées comme une indication que ces tendances ou activités se poursuivront à l'avenir. En outre, même si les résultats ou développements réels sont conformes aux déclarations prospectives contenues dans le présent communiqué de presse, ces résultats ou développements ne sont pas nécessairement indicatifs des résultats ou développements futurs. Aucune déclaration ni garantie n'est faite quant à l'exactitude ou à l'équité de ces déclarations prospectives. Par conséquent, la Société décline expressément toute obligation ou engagement de publier des mises à jour ou des révisions des déclarations prospectives contenues dans le présent communiqué de presse à la suite d'un changement dans les attentes ou d'un changement dans les événements, les conditions, les hypothèses ou les circonstances sur lesquels ces déclarations prospectives sont fondées, sauf si la loi ou la réglementation l'exige expressément. Ni la Société, ni ses conseillers ou représentants, ni aucune de ses filiales, ni aucun des dirigeants ou employés de ces personnes ne garantissent que les hypothèses sous-jacentes à ces déclarations prospectives sont exemptes d'erreurs, et n'acceptent aucune responsabilité quant à l'exactitude future des déclarations prospectives contenues dans le présent communiqué de presse ou à la réalisation effective des développements prévus. Vous ne devez pas vous fier indûment aux déclarations prospectives, qui ne sont valables qu'à la date du présent communiqué de presse.

Contacts :

Nyxoah
John Landry, CFO
[email protected]

Rémi Renard
Head of Investor Relations & Corporate Communication
[email protected]

Pièce jointe


GLOBENEWSWIRE (Distribution ID 1001165373)

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

Mont-Saint-Guibert, Belgium – February 18, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced continued progress in strengthening its presence in the Middle East through the signature of a Memorandum of Understanding (MoU) with Sheikh Shakhbout Medical City (SSMC), a flagship hospital in the United Arab Emirates for serious and complex care and a subsidiary of PureHealth, the largest healthcare group in the Middle East. This MoU reflects Nyxoah’s strategic focus on working with leading regional medical centers to expand access to its Genio® hypoglossal nerve stimulation (HGNS) therapy, while supporting the highest standards of clinical care, education, and scientific collaboration.

As part of this MoU, Nyxoah and SSMC are engaged in initiatives aimed at positioning SSMC as a leading regional center for Genio therapy. These efforts are intended to support the development of a high-volume implant program with a strong focus on patient-centered care.

In parallel, the collaboration includes plans to establish SSMC as a regional training hub for Genio therapy in the Middle East to support the education of surgeons, sleep physicians, and referring healthcare professionals from across the region.

Nyxoah and SSMC are also engaged in discussions to explore clinical research and collaboration in the field of sleep apnea, chronic and metabolic disease management.

Olivier Taelman, Chief Executive Officer of Nyxoah, commented: “Given the high prevalence of Obstructive Sleep Apnea in the Middle East, this initiative supports our vision to offer new treatment options to patients in the region and further explore the impact of advanced OSA management on chronic and metabolic diseases such as type 2 diabetes. Our active engagement with Sheikh Shakhbout Medical City reflects our strategy of partnering with leading institutions to build sustainable clinical programs, support physician education, and contribute to the advancement of care for patients living with obstructive sleep apnea.”

Dr. Marwan Al Kaabi, Chief Executive Officer of Sheikh Shakhbout Medical City, added: “At Sheikh Shakhbout Medical City, we are committed to advancing specialized, high-quality care through clinical excellence, education, and research. Our collaboration with Nyxoah supports our efforts to further develop expertise in innovative sleep apnea therapies and to serve as a regional reference center for training and scientific exchange.”

About Nyxoah

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat OSA. Nyxoah’s lead solution is the Genio system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study and receipt of approval from the FDA for a subset of adult patients with moderate to severe OSA with an AHI of greater than or equal to 15 and less than or equal to 65.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. FDA approved in August 2025 as prescription-only device.

Forward-looking statements

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or management’s current expectations regarding the Genio system; the potential advantages of the Genio system; Nyxoah’s goals with respect to the potential use of the Genio system; the Company's commercialization strategy and entrance to the U.S. market; the Company's results of operations, financial condition, liquidity, performance, prospects, growth, future revenue and strategies. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. These risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2024, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2025 and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward- looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contacts:
Nyxoah
John Landry, CFO
[email protected]

Rémi Renard
Head of Investor Relations & Corporate Communication
[email protected]

Attachment


GLOBENEWSWIRE (Distribution ID 1001165373)

Jetex Abu Dhabi and Jetex Dubai Achieve World’s First Private Airport Terminal Verification from Forbes Travel Guide

Dubai, Feb. 18, 2026 (GLOBE NEWSWIRE) — Jetex, a global leader in private aviation, is proud to announce that its flagship private terminals in Dubai and Abu Dhabi have become the first in the world to receive the VERIFIED™ badge, a prestigious honor from Forbes Travel Guide.

Since its establishment in 1958, the Forbes Travel Guide has become the global authority on luxury hospitality, best known for its independent, annual Star Ratings for hotels, restaurants, spas and ocean cruises.

Jetex partnered with ATELIER CX, Forbes Travel Guide’s consulting division, to define standards of excellence for all aspects of the guest experience including reservations, pre- and post-flight and chauffeur service. After engaging in training for its teams, Jetex Dubai and Jetex Abu Dhabi earned the VERIFIED™ Private Jet Terminal accolade through successful incognito inspection on its exacting brand standards.

“We are proud to be the first in the world to earn this honor from Forbes Travel Guide for both our flagship terminals in the United Arab Emirates. Luxury hospitality and exceptional guest experience are integrated in the Jetex brand DNA, and allow us to grow our presence globally,” said Adel Mardini, Founder & CEO of Jetex.

Committed to delivering the highest luxury hospitality standards, Jetex continues working closely with Forbes Travel Guide Learning & Development experts to further elevate guest experience at its private terminals.

“We celebrate Jetex for its commitment to excellence,” said Hermann Elger, CEO of Forbes Travel Guide. “By defining a comprehensive blueprint for service that meets —and anticipates — the expectations of a discerning global clientele, Jetex has successfully translated the principles of world-class hospitality into the private air terminal space.”

A reflection of excellence, Jetex will offers its guests a unique and personalized travel experience globally. From the warm welcome to the attentive service, every detail elevates the journey, in an atmosphere of refinement and serenity embodied by the Jetex associates.

– END –

About Jetex:
An award-winning global leader in executive aviation, Jetex is recognized for delivering flexible, best-in-class trip support solutions to customers worldwide. Jetex provides exceptional private terminals (FBOs), aircraft fueling, ground handling and global trip planning. The company caters to both owners and operators of business jets for corporate, commercial and personal air travel. To find out more about Jetex, visit www.jetex.com and follow us on Instagram, Twitter, Facebook, and LinkedIn.

About Forbes Travel Guide

Forbes Travel Guide (“FTG”), the global authority on genuine Five-Star service, provides world-class professional services through its consulting division ATELIER CX to service-oriented businesses such as luxury retail, residential, healthcare and private clubs through bespoke training solutions, evaluation services and custom service standards.

Press Enquiries:
Oleg Kafarov
Vice President of Public Relations
T: +971 4 212 4900
E: [email protected]

Attachments


GLOBENEWSWIRE (Distribution ID 9656744)

WENDEL: Wendel supports MTN’s offer to acquire IHS Towers pursuant to which it will receive full liquidity on its 19% stake, representing net proceeds of approximately $535m

  PRESS RELEASE – FEBRUARY 17, 2026

Wendel supports MTN’s offer to acquire IHS Towers pursuant to which it will receive full liquidity on its 19% stake, representing net proceeds of approximately $535m

Wendel (Euronext: MF.FP) today announces its support for the offer (the “Offer”) made by an affiliate company of MTN Group to acquire IHS Holding Limited (NYSE: IHS) (“IHS Towers” or the “Company”). The Offer has been approved by the board of directors of IHS Towers.

At $8.5 per share, the Offer represents a premium of 36% to the 52-week volume-weighted average price (VWAP) as of February 4, 2026.

Upon closing, Wendel will receive full liquidity on its c.19% stake in IHS, representing proceeds of approximately $535m to Wendel. The selling price represents a 21% premium over Wendel’s latest reported Net Asset Value (September 30, 2025).

Closing of the transaction is expected to occur in 2026, subject to IHS shareholder approval, regulatory approvals in the relevant markets, and customary closing conditions.

Founded in 2001, IHS Towers is one of the largest independent owners, operators and developers of shared communications infrastructure in the world by tower count with a sole focus on the emerging markets. The company has over 37,000 towers across its seven markets, including Brazil, Cameroon, Colombia, Côte d'Ivoire, Nigeria, South Africa and Zambia.

Wendel has been one of IHS's largest minority shareholder since 2012 and has supported the company throughout its journey to become one of the largest independent towercos focused on emerging markets. Since Wendel’s initial investment, IHS has grown from approximately 1,000 towers in one country to more than 37,000 towers across seven countries. Over the past 13 years, IHS has expanded significantly and grew to become a $1.8bn revenue company, delivering EBITDA margins in excess of 55 % of revenue. Following the Company’s IPO on the NYSE in October 2021, Wendel has maintained its ownership unchanged.

Laurent Mignon, Wendel Group CEO, commented: “Wendel has been IHS’s partner for more than a decade and has supported its development. The combination of MTN and IHS is an industrial project that makes sense, and which Wendel fully supports by tendering its shares to MTN’s offer. This disposal enables Wendel to continue refocusing its strategy on direct investments in controlled, unlisted companies located in Europe and North America.

Furthermore, this transaction is fully aligned with the active portfolio rotation strategy presented at the Investor Day in December 2025 and already recently illustrated by the sale of Stahl to Henkel, announced on February 4. Together, these two transactions will generate approximately €1.65 billion and give Wendel full flexibility to achieve its long-term value creation objectives through investments in private assets, the development of Wendel Investment Managers (WIM), and a higher return to shareholders, notably with the launch —following the announcement of our annual results— of a share buyback program representing nearly 9% of the share capital.”

Sam Darwish, IHS Towers Chairman and CEO: “Today’s announcement creates a compelling opportunity that provides certainty and immediate returns for our shareholders, enabling them to crystallize the significant value generated during our strategic review. The proposed transaction deepens our long-standing partnership with MTN, as it combines Africa’s largest mobile network operator with one of its largest digital infrastructure platforms, and underscores the strong connection between IHS Towers and the African continent.

I would like to take this opportunity to thank our colleagues, customers and partners for their support over the past 25 years, as IHS Towers has grown from a single tower in one market to an eleven-country portfolio of approximately 40,000 towers at its peak.”

Ralph Mupita, Group President and CEO, MTN, commented: “This proposed transaction is a pivotal step in further strengthening MTN Group’s strategic and financial position for a future where digital infrastructure will become ever more essential to Africa’s growth and development. This transaction gives us a unique opportunity to buy back our towers and strengthen our ability to be partners for progress to the nation states in which we operate. For IHS customers and partners across the continent, we commit to continuing high standards of service and the right governance of what is the largest standalone and integrated tower company in Africa, enabled by the excellent people within IHS.”

Agenda  
   
Thursday, February 26, 2026  
Full-Year 2025 Results – Publication of NAV as of December 31, 2025, and Full-Year consolidated financial statements (before-market release)  
  
Thursday, April 23, 2026  
Q1 2026 Trading update – Publication of NAV as of March 31, 2026 (before-market release)  
  
 Thursday, May 21, 2026  
Annual General Meeting   
  
 Thursday, July 30, 2026  
 H1 2026 results – Publication of NAV as of June 30, 2026, and condensed Half-Year consolidated financial statements (before-market release)  
   
About Wendel 
Wendel is one of Europe’s leading listed investment firms. Regarding its Principal Investments strategy, the Group invests in companies which are leaders in their field, such as ACAMS, Bureau Veritas, Crisis Prevention Institute, Globeducate, IHS Towers, Scalian, Stahl, Muno and Tarkett. In 2023, Wendel initiated a strategic shift into third-party asset management of private assets, alongside its historical principal investment activities. In May 2024, Wendel completed the acquisition of a 51% stake in IK Partners, a major step in the deployment of its strategic expansion in third-party private asset management ,completed in March 2025 the acquisition of 72% of Monroe Capital and announced the acquisition of Committed Advisors in October 2025. As of September 30, 2025, Wendel Investment Managers manages 46 billion euros on behalf of third-party investors, pro forma of the acquisition of Committed Advisors, and c.5.3 billion euros invested in its Principal Investments activity.  
Wendel is listed on Eurolist by Euronext Paris. 
Standard & Poor’s ratings: Long-term: BBB, stable outlook – Short-term: A-2  
Wendel is the Founding Sponsor of Centre Pompidou-Metz. In recognition of its long-term patronage of the arts, Wendel received the distinction of “Grand Mécène de la Culture” in 2012. 
For more information: wendelgroup.com 
Follow us on LinkedIn @Wendel  
   

Press contacts  Analyst and investor contacts
Christine Anglade: +33 6 14 04 03 87          Olivier Allot: +33 1 42 85 63 73
[email protected] [email protected]
   
Caroline Decaux: +33 1 42 85 91 27              Lucile Roch: +33 1 42 85 63 72
[email protected]    [email protected]
   
Primatice  
Olivier Labesse: +33 6 79 11 49 71  
[email protected]  
Hugues Schmitt: +33 6 71 99 74 58  
[email protected]  
   
Kekst CNC  
Todd Fogarty: +1 212 521 4854  
[email protected]  

 

Attachment


GLOBENEWSWIRE (Distribution ID 1001165223)

WENDEL : Wendel soutient l'offre d'acquisition d'IHS Towers par MTN, qui permettra de céder l'intégralité de sa participation de 19 %, représentant environ 535 millions de dollars de liquidités nettes. 

 COMMUNIQUE – 17 février 2026

Wendel soutient l'offre d'acquisition d'IHS Towers par MTN, qui permettra de céder l'intégralité de sa participation de 19 %, représentant environ 535 millions de dollars de liquidités nettes. 

Wendel (Euronext : MF.FP) annonce aujourd'hui son soutien à l'offre (l'« Offre ») faite par une société affiliée du groupe MTN en vue d'acquérir IHS Holding Limited (NYSE : IHS) (« IHS Towers » ou la « Société »). L'Offre a été approuvée par le conseil d'administration d'IHS Towers.

À 8,5 dollars par action, l'offre représente une prime de 36 % par rapport au cours moyen pondéré (Volume Weighted Average Price) de l'action sur les 52 semaines précédant le 4 février 2026.

À la clôture de l’opération, Wendel recevra la totalité des liquidités correspondant à sa participation d'environ 19 % dans IHS, soit un produit de cession d'environ 535 millions de dollars pour Wendel. Le prix de vente représente une prime de 21 % par rapport à la dernière valeur dans l’ANR publié par Wendel (30 septembre 2025).

La clôture de la transaction devrait avoir lieu en 2026, sous réserve de l’approbation des actionnaires d’IHS, des autorisations réglementaires dans les marchés concernés et du respect des conditions habituelles de clôture.

        

Fondée en 2001, IHS Towers est l'un des plus grands propriétaires, opérateurs et constructeurs indépendants d'infrastructures partagées de télécommunication dans le monde en nombre de tours et se concentre uniquement sur les marchés émergents. La société possède plus de 37 000 tours réparties sur ses sept marchés, soit au Brésil, au Cameroun, en Colombie, en Côte d'Ivoire, au Nigeria, en Afrique du Sud et en Zambie.

Wendel est l'un des principaux actionnaires minoritaires d'IHS depuis 2012, et a soutenu l'entreprise tout au long de son parcours pour devenir l'une des plus grandes sociétés indépendantes de tours de télécommunication axées sur les marchés émergents, faisant croître son nombre de tours d’environ 1 000 au sein d’un seul un pays à plus de 37 000 tours dans 7 pays. Au cours des 13 dernières années, IHS s'est développé sur de nouveaux marchés et a connu une croissance significative pour devenir une entreprise générant 1,8 milliard de dollars de chiffre d'affaires et affichant une marge EBITDA supérieure à 55 % du chiffre d'affaires. La société a été introduite en octobre 2021 à la bourse de New York, Wendel conservant sa participation inchangée.

Laurent Mignon, Président du Directoire de Wendel, a déclaré : « Wendel a été le partenaire d'IHS pendant plus de dix ans et a accompagné son développement. Le rapprochement entre MTN et IHS est un projet industriel qui fait sens et que Wendel soutient pleinement en apportant ses titres à l’offre de MTN. Cette cession permet à Wendel de poursuivre le recentrage de sa stratégie d’investissement direct (WPI : Wendel Principal Investments) en se concentrant sur des sociétés non cotées, contrôlées et situées en Europe et en Amérique du Nord. Par ailleurs, cette opération est pleinement alignée avec la stratégie de rotation active du portefeuille présentée lors de l’Investor Day de décembre 2025 et déjà illustrée récemment par la cession de Stahl à Henkel annoncée le 4 février dernier. Ensemble, ces deux transactions permettront de générer environ 1,65 milliard d’euros et donnent à Wendel toutes les marges de manœuvres pour réaliser ses objectifs de création de valeur à long terme au travers d’investissements dans des actifs privés, au développement de Wendel Investment Managers (WIM), et un retour aux actionnaires plus élevé avec notamment le lancement après l’annonce de nos résultats annuels d’un programme de rachat d’actions portant sur près de 9 % du capital. »

Sam Darwish, Président-Directeur Général d'IHS Towers : « L'annonce d'aujourd'hui constitue une réelle opportunité, offrant certitude et retour immédiat à nos actionnaires, leur permettant ainsi de cristalliser la valeur générée par notre revue stratégique. La transaction proposée renforce notre partenariat de longue date avec MTN, car elle associe le plus grand opérateur de réseau mobile d'Afrique à l'une des plus grandes plateformes d'infrastructure numérique du continent, et souligne le lien fort unissant IHS Towers et l'Afrique.
Je voudrais profiter de cette occasion pour remercier nos collègues, nos clients et nos partenaires pour leur soutien au cours des 25 dernières années, pendant lesquelles IHS Towers est passé d'une seule tour sur un seul marché à un portefeuille d'environ 40 000 tours dans onze pays à son apogée.»

Ralph Mupita, Président-Directeur Général de MTN: « La transaction est une étape cruciale dans le renforcement de la position stratégique et financière du groupe MTN, dans un avenir où les infrastructures numériques deviendront de plus en plus essentielles à la croissance et au développement de l'Afrique. Cette transaction nous offre une occasion unique de racheter nos tours et de renforcer notre capacité à être des partenaires du progrès pour les nations dans lesquelles nous opérons. Pour les clients et partenaires d'IHS à travers le continent, nous nous engageons à maintenir des normes de service élevées et une gouvernance adéquate de ce qui est la plus grande société indépendante et intégrée de tours en Afrique, grâce à l'excellence des collaborateurs d'IHS.»

Agenda 
  
Jeudi 26 février 2026 
Résultats annuels 2025  – Publication de l’ANR au 31 décembre 2025, et comptes annuels consolidés (avant bourse) 

Jeudi 23 avril 2026 
Chiffre d’affaires T1 2026  – Publication de l’ANR au 31 mars 2026 (avant bourse) 

 Jeudi 21 mai 2026 
Assemblée générale  

Jeudi 30 juillet 2026 
Résultats semestriels 2026 – Publication de l’ANR au 30 juin 2026 et comptes semestriels consolidés (avant bourse)  

À propos de Wendel 
Wendel SE est l’une des toutes premières sociétés d’investissement cotées en Europe. Dans le cadre de son activité d’investissement pour compte propre, elle investit dans des sociétés leaders dans leur secteur : ACAMS, Bureau Veritas, Crisis Prevention Institute, Globeducate, IHS Towers, Scalian, Stahl, Muno et Tarkett. En 2023, Wendel a annoncé son intention de développer une plateforme de gestion d'actifs privés pour compte de tiers en complément de ses activités d'investissement pour compte propre. Dans ce cadre, Wendel a finalisé les acquisitions de 51 % d’IK Partners en mai 2024, de 72 % de Monroe Capital en mars 2025 et annoncé l’acquisition de Committed Advisors en octobre 2025. Au 30 septembre 2025, le Groupe gère 46 Mds d’euros pour le compte d’investisseurs tiers, pro forma de l’acquisition de Committed Advisors, et environ 5,3 Mds d’euros investis pour compte propre.
Wendel est cotée sur l’Eurolist d’Euronext Paris.  
Notation attribuée par Standard & Poor’s : Long terme : BBB avec perspective stable — Court terme : A-2  
Wendel est le Mécène Fondateur du Centre Pompidou-Metz. En raison de son engagement depuis de longues années en faveur de la Culture, Wendel a reçu le titre de Grand Mécène de la Culture en 2012. 
Pour en savoir plus : wendelgroup.com 
Suivez-nous sur LinkedIn @Wendel  

Contacts journalistes Contacts analystes et investisseurs
Christine Anglade: + 33 6 14 04 03 87          Olivier Allot: +33 1 42 85 63 73
[email protected] [email protected]
   
Caroline Decaux: +33 1 42 85 91 27              Lucile Roch: +33 1 42 85 63 72
[email protected]    [email protected]
   
Primatice  
Olivier Labesse: +33 6 79 11 49 71  
[email protected]  
Hugues Schmitt: +33 6 71 99 74 58  
[email protected]  
   
Kekst CNC  
Todd Fogarty: +1 212 521 4854  
[email protected]  

Pièce jointe


GLOBENEWSWIRE (Distribution ID 1001165223)